Although TRPM2 channels have been implicated in most cardiovascular and metabolic diseases [33,34,37,38] (Table 1), early insights into the underlying signalling mechanisms are only just beginning to emerge (reviewed in [17]). The gene discussed is TRPM2; the disease is metabolic disease.